These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1003 related articles for article (PubMed ID: 35065680)

  • 1. Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies.
    Padella A; Ghelli Luserna Di Rorà A; Marconi G; Ghetti M; Martinelli G; Simonetti G
    J Hematol Oncol; 2022 Jan; 15(1):10. PubMed ID: 35065680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders.
    Faraoni I; Giansanti M; Voso MT; Lo-Coco F; Graziani G
    Biochem Pharmacol; 2019 Sep; 167():133-148. PubMed ID: 31028744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword.
    Csizmar CM; Saliba AN; Swisher EM; Kaufmann SH
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34945003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors.
    Esposito MT; Zhao L; Fung TK; Rane JK; Wilson A; Martin N; Gil J; Leung AY; Ashworth A; So CW
    Nat Med; 2015 Dec; 21(12):1481-90. PubMed ID: 26594843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARP goes the weasel! Emerging role of PARP inhibitors in acute leukemias.
    Fritz C; Portwood SM; Przespolewski A; Wang ES
    Blood Rev; 2021 Jan; 45():100696. PubMed ID: 32482307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic.
    Cerrato A; Morra F; Celetti A
    J Exp Clin Cancer Res; 2016 Nov; 35(1):179. PubMed ID: 27884198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide-Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C.
    Giansanti M; De Gabrieli A; Prete SP; Ottone T; Divona MD; Karimi T; Ciccarone F; Voso MT; Graziani G; Faraoni I
    J Pharmacol Exp Ther; 2021 Jun; 377(3):385-397. PubMed ID: 33820831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unifying targeted therapy for leukemia in the era of PARP inhibition.
    Boila LD; Sengupta A
    Exp Hematol; 2023 Aug; 124():1-14. PubMed ID: 37236341
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Molenaar RJ; Radivoyevitch T; Nagata Y; Khurshed M; Przychodzen B; Makishima H; Xu M; Bleeker FE; Wilmink JW; Carraway HE; Mukherjee S; Sekeres MA; van Noorden CJF; Maciejewski JP
    Clin Cancer Res; 2018 Apr; 24(7):1705-1715. PubMed ID: 29339439
    [No Abstract]   [Full Text] [Related]  

  • 10.
    Maifrede S; Le BV; Nieborowska-Skorska M; Golovine K; Sullivan-Reed K; Dunuwille WMB; Nacson J; Hulse M; Keith K; Madzo J; Caruso LB; Gazze Z; Lian Z; Padella A; Chitrala KN; Bartholdy BA; Matlawska-Wasowska K; Di Marcantonio D; Simonetti G; Greiner G; Sykes SM; Valent P; Paietta EM; Tallman MS; Fernandez HF; Litzow MR; Minden MD; Huang J; Martinelli G; Vassiliou GS; Tempera I; Piwocka K; Johnson N; Challen GA; Skorski T
    Cancer Res; 2021 Oct; 81(19):5089-5101. PubMed ID: 34215619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF-positive leukemic cells.
    Piao J; Takai S; Kamiya T; Inukai T; Sugita K; Ohyashiki K; Delia D; Masutani M; Mizutani S; Takagi M
    Cancer Lett; 2017 Feb; 386():131-140. PubMed ID: 27894958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors.
    Hopkins TA; Shi Y; Rodriguez LE; Solomon LR; Donawho CK; DiGiammarino EL; Panchal SC; Wilsbacher JL; Gao W; Olson AM; Stolarik DF; Osterling DJ; Johnson EF; Maag D
    Mol Cancer Res; 2015 Nov; 13(11):1465-77. PubMed ID: 26217019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partnering with PARP inhibitors in acute myeloid leukemia with FLT3-ITD.
    Dellomo AJ; Baer MR; Rassool FV
    Cancer Lett; 2019 Jul; 454():171-178. PubMed ID: 30953707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome.
    Kontandreopoulou CN; Diamantopoulos PT; Tiblalexi D; Giannakopoulou N; Viniou NA
    Blood Adv; 2021 Nov; 5(22):4794-4805. PubMed ID: 34529761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-Damage-Repair Gene Alterations in Genitourinary Malignancies.
    Dariane C; Timsit MO
    Eur Surg Res; 2022; 63(4):155-164. PubMed ID: 35944490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Poly(ADP-ribose) Polymerase Inhibitor, Pamiparib (BGB-290) in Treating Acute Myeloid Leukemia and the Characterization of Its Nanocarrier.
    Xu X; Wang J; Tong T; Lin SF; Liu C; Zhou D
    J Biomed Nanotechnol; 2021 Nov; 17(11):2165-2175. PubMed ID: 34906277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond.
    Boussios S; Abson C; Moschetta M; Rassy E; Karathanasi A; Bhat T; Ghumman F; Sheriff M; Pavlidis N
    Drugs R D; 2020 Jun; 20(2):55-73. PubMed ID: 32215876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Damage Repair and the Emerging Role of Poly(ADP-ribose) Polymerase Inhibition in Cancer Therapeutics.
    Rabenau K; Hofstatter E
    Clin Ther; 2016 Jul; 38(7):1577-88. PubMed ID: 27368114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PARP-inhibitor-induced synthetic lethality for acute myeloid leukemia treatment.
    Zhao L; So CW
    Exp Hematol; 2016 Oct; 44(10):902-7. PubMed ID: 27473567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DNA damaging revolution.
    Cetin B; Wabl CA; Gumusay O
    Crit Rev Oncol Hematol; 2020 Dec; 156():103117. PubMed ID: 33059228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.